Kenvue INC Form 4 insider transactions

NYSE
Kenvue Inc. and Kimberly-Clark have initiated formalized integration planning for their anticipated combination, expected in the second half of 2026, appointing Russ Torres as Integration Lead.
NYSE
Kenvue Director Jeffrey C. Smith filed a Form 4, reporting his indirect beneficial ownership of 20.9 million common shares and the acquisition of 1,451 Deferred Share Units.
NYSE
Kimberly-Clark's leadership discusses the strategic rationale behind the Kenvue acquisition, emphasizing synergy potential and a plan to revitalize Kenvue's brands while maintaining momentum in its core business.
NYSE
Kenvue Inc. Director Sarah Hofstetter acquired 1,451 Deferred Share Units as part of a compensation deferral plan.
NYSE
Kenvue's General Counsel, Matthew Orlando, reported the vesting and subsequent tax-related sale of company common stock.
NYSE
Kenvue Inc.'s Group President for EMEA & LA, Carlton Lawson, increased his direct beneficial ownership by 1,779 common shares following the vesting of restricted stock units.
NYSE
Kenvue's Chief Operations Officer, Meredith Stevens, reported the vesting of Restricted Stock Units and a subsequent sale of shares to cover tax obligations.
NYSE
Kenvue Director Richard E. Allison Jr. acquired 1,451 Deferred Share Units, increasing his beneficial ownership to over 35,900 units.
NYSE
Kenvue's Chief People Officer, Luani Alvarado, reported the vesting of restricted stock units and subsequent shares withheld for tax obligations.
NYSE
Kenvue's Chief Scientific Officer, Caroline Tillett, reported the acquisition of common stock through RSU vesting and subsequent tax-related dispositions.
NYSE
Kimberly-Clark's DTS leadership discusses the Kenvue acquisition, leadership changes, and strategic project resequencing amidst a focus on growth and employee well-being.
NYSE
Kenvue's Chief People Officer, Luani Alvarado, reported the conversion of Restricted Stock Units into common stock and subsequent tax-related share dispositions.
NYSE
Kenvue's Chief Operations Officer, Meredith Stevens, reported the vesting of Restricted Stock Units and subsequent tax-related share dispositions.
NYSE
Kimberly-Clark's CHRO announced a proposed transaction with Kenvue, aiming to create a preeminent global health and wellness leader.
NYSE
Kenvue Inc. announced its planned combination with Kimberly-Clark Corporation, aiming to create a leading consumer health and personal care powerhouse by the second half of 2026.
NYSE
Kimberly-Clark Corporation and Kenvue Inc. have announced a proposed transaction, with an infographic posted on November 14, 2025, detailing the merger.
NYSE
Kenvue Inc. issued an employee communication clarifying the impact of its proposed transaction with Kimberly-Clark Corporation on compensation, benefits, and equity.
NYSE
Kenvue announces an agreement to be acquired by Kimberly-Clark, creating a $32 billion global health and wellness leader.
NYSE
Kimberly-Clark Corporation and Kenvue Inc. have announced a proposed transaction, with further details to be filed with the SEC.
NYSE
Kimberly-Clark's Chief Strategy Officer announced a proposed transaction with Kenvue, aiming to create a preeminent global health and wellness leader.
NYSE
Kimberly-Clark Corporation announced its acquisition of Kenvue Inc. for over $40 billion, aiming to create the second-largest consumer packaged goods company globally, despite an immediate 14% stock drop.
NYSE
Kimberly-Clark CEO Michael Hsu discusses the proposed merger with Kenvue, highlighting significant value creation, complementary portfolios, and confidence in addressing legal challenges.
NYSE
Kimberly-Clark Corporation and Kenvue Inc. confirm a proposed transaction, urging investors to review upcoming SEC filings for details.
NYSE
Kenvue Inc.'s CFO, Amit Banati, published a LinkedIn post regarding a proposed transaction with Kimberly-Clark Corporation, prompting an SEC filing.
NYSE
Kimberly-Clark announces a transformational acquisition of Kenvue, aiming to create the largest pure-play consumer health company with combined annual revenues of $32 billion and $7 billion EBITDA.
NYSE
Kimberly-Clark and Kenvue Inc. filed a Rule 425 communication regarding their proposed transaction, emphasizing the need for investor review of proxy materials.
NYSE
Kimberly-Clark and Kenvue announce plans to merge, aiming to create a global health and wellness leader by combining their iconic brands and commitment to care.
NYSE
Kimberly-Clark Corporation and Kenvue Inc. have announced a proposed transaction, urging investors to review forthcoming detailed SEC filings for comprehensive information.
NYSE
Kimberly-Clark and Kenvue disclose plans for a proposed transaction, urging investors to review upcoming SEC filings for full details.
NYSE
Kimberly-Clark and Kenvue announced their intent to combine, creating a global health and wellness leader with complementary portfolios of iconic brands.